COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 82 of 89 for:    DESVENLAFAXINE

Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02893371
Recruitment Status : Unknown
Verified October 2017 by Christophe Gerard Lambert, University of New Mexico.
Recruitment status was:  Enrolling by invitation
First Posted : September 8, 2016
Last Update Posted : October 13, 2017
Patient-Centered Outcomes Research Institute
Montana State University
National Alliance on Mental Illness
Risk Benefit Statistics LLC
Information provided by (Responsible Party):
Christophe Gerard Lambert, University of New Mexico